Coronavirus Pandemic Matters Sample Clauses

Coronavirus Pandemic Matters. (a) None of the Success Subject Companies applied for, or received, any relief from Taxes or other Tax benefit under the CARES Act or any other Coronavirus Pandemic-related Law, including claiming an employee retention credit or deferring any amount of employer or employee pay-roll Taxes. (b) Except as set forth on Section 3.27(b) of the Seller Disclosure Letter, none of the Success Subject Companies applied for, or received, any loans under the CARES Act or any other Coronavirus Pandemic-related Law, including any loans pursuant to the Paycheck Protection Program, any economic injury disaster loans from the U.S. Small Business Administration or any grants from the U.S. Department of Health and Human Services (HHS) under the CARES Act Provider Relief Fund.
Sample 1Sample 2
AutoNDA by SimpleDocs
Coronavirus Pandemic Matters. 37 Section 2.31 No Other Representations or Warranties..............................................38 ARTICLE 3
Sample 1
Coronavirus Pandemic Matters. (a) With respect to the PPP Loan: (i) Xxxxxxx was eligible pursuant to the Paycheck Protection Program Laws to apply for and receive the PPP Loan; (ii) Xxxxxxx was, at all times, in compliance in all material respects with all of the terms and conditions of the PPP Loan and the requirements of the Paycheck Protection Program Laws applicable to the PPP Loan; and (iii) all of the proceeds of the PPP Loan were utilized for forgiveness eligible or other allowable uses as proscribed in the Paycheck Protection Program Laws. Sellers have made available true, accurate, and complete copies of all documents received by Xxxxxxx from the PPP Lender or any Governmental Authority with respect to the PPP Loan. Other than the PPP Loan, none of the Acquired Companies has received any loan under the Paycheck Protection Program administrated by the U.S. Small Business Administration. Xxxxxxx timely submitted application(s) for forgiveness of the PPP Loan and the PPP Loan was forgiven in full on June 10, 2021. Sellers have made (b) Other than the PPP Loan, the Acquired Companies have not received any other loans, grants, or funding from any government programs or any other third person as a result of or in connection with the Coronavirus Pandemic. (c) None of the Acquired Companies applied for, or received, any relief from Taxes or other Tax benefit under the CARES Act or any other Coronavirus Pandemic-related Law, including claiming an employee retention credit or deferring any amount of employer or employee pay-roll Taxes.
Sample 1
Coronavirus Pandemic Matters. (a) Disclosure Schedule 5.22(a) sets forth all loans received by the Company under the CARES Act, including any PPP Loans. The Company has provided to the Purchaser true, correct, and complete copies of all documents received by the Company or its Subsidiaries with respect to any such PPP Loans. Except as set forth on Disclosure Schedule 5.22(a), the Company and its Subsidiaries are in full compliance with the terms of the PPP Loans, including the applicable requirements governing the Company’s or its Subsidiaries’ application for PPP Loans and all related certifications, and all such related certifications were, and are currently, true and correct. The Company and its Subsidiaries are in compliance in all material respects with all requirements for the PPP Loans to allow the PPP loans to be forgiven in full, and the Company expect that the Company and its Subsidiaries will remain in compliance in all material respects with all such requirements. The Company and its Subsidiaries have used all of the proceeds of the PPP Loans only for the purposes permitted under the applicable Laws promulgated under the CARES Act or other rulemaking with respect to the PPP Loans. (b) Other than the PPP Loans set forth on Disclosure Schedule 5.22(a), if any, the Company and its Subsidiaries have not received any other loans, grants, or funding from any government programs or any other third person as a result of or in connection with the Coronavirus Pandemic.
Sample 1
Coronavirus Pandemic Matters. 47 SECTION 4.31. International Trade ....................................................................................... 48 SECTION 4.32. Indebtedness and Transaction Expenses ...................................................... 49 SECTION 4.33. Disclosure; No Other Representations and Warranties ................................ 49 ARTICLE V BUYER PARTY REPRESENTATIONS AND WARRANTIES ....................................... 49 SECTION 5.01. Organization; Power; Execution .................................................................. 49 SECTION 5.02.
Sample 1
Coronavirus Pandemic Matters. Schedule 4.30(a) sets forth all loans, grants, or funding received by each Company Entity under any Coronavirus Relief Programs, including any PPP Loan and any EIDL/RRF Grant. The Seller Parties have made available to Buyer true, correct, and complete copies of all documents received by any Company Entity or any Seller Party with respect to each PPP Loan, EIDL/RRF Grant and/or any other Coronavirus Relief Program (collectively, the “Coronavirus Relief Loans”). In obtaining and applying for the Coronavirus Relief Loans, each Company Entity satisfied all eligibility and certification requirements at the time of the application for the Coronavirus Relief Loans. All certifications made by the Company Entities to the applicable lenders in connection with the Coronavirus Relief Loans (including on the application for the PPP Loans) were, at the time made, true, correct and made in good faith. Each Company Entity has complied in all material respects with the requirements of all loan programs that such Company Entity participated in under the CARES Act (or any similar legislation), including any restrictions on the use of any borrowed funds. Other than the PPP Loans and EIDL/RRF Grants set forth on Schedule 4.30(a), no Company Entity has received any other loans, grants, or funding from any government programs or any other third Person as a result of or in connection with the Coronavirus Pandemic. Except as set forth on Schedule 4.30(a), no Company Entity is subject to (nor has it received an exclusion from the applicable Governmental Entity from) any COVID-19 Measures, such that each Company Entity may continue to operate in the ordinary course of business (which, for the purpose of this Section 4.30(a), shall mean the ordinary course of business of the Company Entities prior to January 1, 2020).
Sample 1

Related to Coronavirus Pandemic Matters

  • Pandemic An epidemic that spreads over a wide area, crossing borders and defined as a pandemic by the World Health Organisation (WHO) and/or by the competent local authorities of the country where the loss occurred. Isolation of the person, in the event of suspected illness or proven illness, decided by a competent local authority, in order to avoid a risk of spreading said illness in the context of an epidemic or pandemic.

  • Environmental, Health and Safety Matters (a) Comply in all material respects with all applicable Environmental Laws, including, without limitation, obtaining and complying with and maintaining any and all licenses, approvals, notifications, registrations or permits required by applicable Environmental Laws. For purposes of this Section 5.12(a), material noncompliance by the Company, any of its Subsidiaries or any tenant or subtenant, with any applicable Environmental Law shall be deemed not to constitute a breach of this covenant provided that, upon learning of any actual or suspected material noncompliance, the Company and the relevant Subsidiaries shall promptly undertake all reasonable efforts to achieve material compliance (or contest in good faith by appropriate proceedings the alleged violation or applicable Environmental Law at issue and (to the extent required by GAAP) provide on the books of the Company or any of its Subsidiaries, as the case may be, reserves in accordance with GAAP with respect thereto), and provided further that, in any case, such noncompliance, and any other noncompliance with applicable Environmental Law, individually or in the aggregate, could not reasonably be expected to have a Material Adverse Effect. (b) Promptly comply in all material respects with all lawful orders and directives of all Governmental Authorities regarding applicable Environmental Laws, except to the extent that the validity thereof is currently being contested in good faith by appropriate proceedings and (to the extent required by GAAP) reserves in accordance with GAAP with respect thereto have been provided on the books of the Company or any of its Subsidiaries, as the case may be. (c) Defend, indemnify and hold harmless the Administrative Agent and the Lenders, and their respective parents, subsidiaries, affiliates, employees, agents, officers and directors, from and against any claims, demands, penalties, fines, liabilities, settlements, damages, costs and expenses of whatever kind or nature, known or unknown, contingent or otherwise, arising out of, or in any way relating to the violation of, noncompliance with or liability under any Environmental Laws applicable to the Company or any of its Subsidiaries or any of their respective operations or properties, or any orders, requirements or demands of Governmental Authorities related thereto, including, without limitation, attorney’s and consultant’s fees, investigation and laboratory fees, response costs, court costs and litigation expenses, except to the extent that any of the foregoing arise out of the gross negligence or willful misconduct of (or, as determined pursuant to a claim initiated by the Company, breach in bad faith of its express obligations under the applicable Loan Documents by) the party seeking indemnification therefor, in each case, as determined by a final non-appealable judgment by a court of competent jurisdiction. This indemnity shall continue in full force and effect regardless of the termination of this Agreement.

  • Hepatitis B Vaccine Where the Hospital identifies high risk areas where employees are exposed to Hepatitis B, the Hospital will provide, at no cost to the employees, a Hepatitis B vaccine.

  • Musculoskeletal Injury Prevention and Control The hospital in consultation with the Joint Health and Safety Committee (JHSC) shall develop, establish and put into effect, musculoskeletal prevention and control measures, procedures, practices and training for the health and safety of employees.

  • Adverse Weather Shall be only weather that satisfies all of the following conditions: (1) unusually severe precipitation, sleet, snow, hail, or extreme temperature or air conditions in excess of the norm for the location and time of year it occurred based on the closest weather station data averaged over the past five years, (2) that is unanticipated and would cause unsafe work conditions and/or is unsuitable for scheduled work that should not be performed during inclement weather (i.e., exterior finishes), and (3) at the Project.

  • Plagiarism The appropriation of another person's ideas, processes, results, or words without giving appropriate credit.

  • Infectious Diseases The Employer and the Union desire to arrest the spread of infectious diseases in the nursing home. To achieve this objective, the Joint Health and Safety Committee may review and offer input into infection control programs and protocols including surveillance, outbreak control, isolation, precautions, worker education and training, and personal protective equipment. The Employer will provide training and ongoing education in communicable disease recognition, use of personal protective equipment, decontamination of equipment, and disposal of hazardous waste.

  • Aggravating and Mitigating Factors The penalties in this matter were determined in consideration of all relevant circumstances, including statutory factors as described in CARB’s Enforcement Policy. CARB considered whether the violator came into compliance quickly and cooperated with the investigation; the extent of harm to public health, safety and welfare; nature and persistence of the violation, including the magnitude of the excess emissions; compliance history; preventative efforts taken; innovative nature and the magnitude of the effort required to comply, and the accuracy, reproducibility, and repeatability of the available test methods; efforts to attain, or provide for, compliance prior to violation; action taken to mitigate the violation; financial burden to the violator; and voluntary disclosure. The penalties are set at levels sufficient to deter violations, to remove any economic benefit or unfair advantage from noncompliance, to obtain swift compliance, and the potential costs, risks, and uncertainty associated with litigation. Penalties in future cases might be smaller or larger depending on the unique circumstances of the case.

  • Professional Development; Adverse Consequences of School Exclusion; Student Behavior The Board President or Superintendent, or their designees, will make reasonable efforts to provide ongoing professional development to Board members about the adverse consequences of school exclusion and justice-system involvement, effective classroom management strategies, culturally responsive discipline, appropriate and available supportive services for the promotion of student attendance and engagement, and developmentally appropriate disciplinary methods that promote positive and healthy school climates, i.e., Senate Bill 100 training topics. The Board will conduct periodic self-evaluations with the goal of continuous improvement. New Board Member Orientation The orientation process for newly elected or appointed Board members includes:

  • Nepotism No employee shall be directly supervised by a member of his/her immediate family. “

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!